GHRS
Price
$14.91
Change
-$0.12 (-0.80%)
Updated
Jul 3 closing price
Capitalization
925.17M
44 days until earnings call
KURA
Price
$5.86
Change
+$0.05 (+0.86%)
Updated
Jul 3 closing price
Capitalization
507.33M
24 days until earnings call
Interact to see
Advertisement

GHRS vs KURA

Header iconGHRS vs KURA Comparison
Open Charts GHRS vs KURABanner chart's image
GH Research
Price$14.91
Change-$0.12 (-0.80%)
Volume$100.07K
Capitalization925.17M
Kura Oncology
Price$5.86
Change+$0.05 (+0.86%)
Volume$781.54K
Capitalization507.33M
GHRS vs KURA Comparison Chart in %
Loading...
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GHRS vs. KURA commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GHRS is a Buy and KURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (GHRS: $14.91 vs. KURA: $5.86)
Brand notoriety: GHRS and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GHRS: 56% vs. KURA: 62%
Market capitalization -- GHRS: $925.17M vs. KURA: $507.33M
GHRS [@Biotechnology] is valued at $925.17M. KURA’s [@Biotechnology] market capitalization is $507.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GHRS’s FA Score shows that 0 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • GHRS’s FA Score: 0 green, 5 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, GHRS is a better buy in the long-term than KURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GHRS’s TA Score shows that 4 TA indicator(s) are bullish while KURA’s TA Score has 3 bullish TA indicator(s).

  • GHRS’s TA Score: 4 bullish, 4 bearish.
  • KURA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, GHRS is a better buy in the short-term than KURA.

Price Growth

GHRS (@Biotechnology) experienced а +20.28% price change this week, while KURA (@Biotechnology) price change was +2.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.51%. For the same industry, the average monthly price growth was +14.00%, and the average quarterly price growth was -0.49%.

Reported Earning Dates

GHRS is expected to report earnings on Aug 20, 2025.

KURA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+5.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GHRS($925M) has a higher market cap than KURA($507M). GHRS YTD gains are higher at: 113.071 vs. KURA (-32.721). GHRS has higher annual earnings (EBITDA): -41.75M vs. KURA (-177.18M). KURA has more cash in the bank: 658M vs. GHRS (291M). GHRS has less debt than KURA: GHRS (658K) vs KURA (19.4M). KURA has higher revenues than GHRS: KURA (68M) vs GHRS (0).
GHRSKURAGHRS / KURA
Capitalization925M507M182%
EBITDA-41.75M-177.18M24%
Gain YTD113.071-32.721-346%
P/E RatioN/AN/A-
Revenue068M-
Total Cash291M658M44%
Total Debt658K19.4M3%
FUNDAMENTALS RATINGS
KURA: Fundamental Ratings
KURA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GHRSKURA
RSI
ODDS (%)
Bearish Trend 5 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
84%
Bullish Trend 5 days ago
80%
Momentum
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
82%
MACD
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 5 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
84%
Advances
ODDS (%)
Bullish Trend 6 days ago
90%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 20 days ago
87%
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
86%
Aroon
ODDS (%)
Bullish Trend 5 days ago
88%
Bearish Trend 5 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRGIX16.190.16
+1.00%
Nuveen Core Equity Retire
DQIYX33.250.24
+0.73%
BNY Mellon Equity Income Fund Y
TADFX8.450.04
+0.48%
Transamerica Sustainable Equity Inc R6
CSPIX15.430.05
+0.33%
Calvert Global Small-Cap Equity I
JCVWX25.720.06
+0.23%
JHancock Classic Value R6

GHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GHRS has been loosely correlated with IVVD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if GHRS jumps, then IVVD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GHRS
1D Price
Change %
GHRS100%
-0.77%
IVVD - GHRS
39%
Loosely correlated
+1.67%
ATAI - GHRS
38%
Loosely correlated
+0.73%
CLDI - GHRS
29%
Poorly correlated
+5.09%
MNMD - GHRS
28%
Poorly correlated
+1.27%
KURA - GHRS
26%
Poorly correlated
+0.86%
More

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with PYXS. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
+0.86%
PYXS - KURA
66%
Loosely correlated
-8.33%
OPORF - KURA
62%
Loosely correlated
N/A
KYMR - KURA
44%
Loosely correlated
+0.58%
ZYME - KURA
44%
Loosely correlated
+1.16%
ADVM - KURA
42%
Loosely correlated
+0.88%
More